Humoral factors in peripheral nerve diseaseTOYKA, K. V; HEININGER, K.Muscle & nerve. 1987, Vol 10, Num 3, pp 222-232, issn 0148-639XArticle

Strategies for the modulation of neuroimmunological disease at the level of autoreactive T-lymphocytesHOLFELD, R; TOYKA, K. V.Journal of neuroimmunology. 1985, Vol 9, Num 3-4, pp 193-204, issn 0165-5728Article

Functional abnormalities in P₀-deficient mice resemble human hereditary neuropathies linked to P₀ gene mutationsZIELASEK, J; MARTINI, R; TOYKA, K. V et al.Muscle & nerve. 1996, Vol 19, Num 8, pp 946-952, issn 0148-639XArticle

Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis ratJUNG, S; TOYKA, K. V; HARTUNG, H.-P et al.Clinical and experimental immunology (Print). 1994, Vol 98, Num 3, pp 494-502, issn 0009-9104Article

T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndromeHARTUNG, H.-P; TOYKA, K. V.Annals of neurology. 1990, Vol 27, pp S57-S63, issn 0364-5134, supplConference Paper

Phorbol diester TPA elicits prostaglandin E release from cultured rat astrocytesHARTUNG, H.-P; TOYKA, K. V.Brain research. 1987, Vol 417, Num 2, pp 347-349, issn 0006-8993Article

Symptomatic treatment of multiple sclerosis : Multiple sclerosis therapy consensus group (MSTCG) of the German multiple sclerosis societyHENZE, T; RIECKMANN, P; TOYKA, K. V et al.European neurology. 2006, Vol 56, Num 2, pp 78-105, issn 0014-3022, 28 p.Article

Reversible conduction block in human ischemic neuropathy after ergotamine abuseHÖMBERG, V; REINERS, K; TOYKA, K. V et al.Muscle & nerve. 1992, Vol 15, Num 4, pp 467-470, issn 0148-639XArticle

Neue Aspekte zur Pathogenese und Therapie des Guillain-Barré-Syndroms und der chronischen Polyneuritis = Recent advances in the pathogenesis and therapy of acute Guillain-Barré syndrome and chronic idiopathic demyclinating polyradiculoneuropathy (CIDP)HARTUNG, H.-P; HEININGER, K; TOYKA, K. V et al.Nervenarzt. 1990, Vol 61, Num 4, pp 197-207, issn 0028-2804, 11 p.Article

Bilateral cerebral emboli monitoring during extra corporeal circulationMÜLLGES, W; BERG, D; TOYKA, K. V et al.Ultrasound in medicine & biology. 1999, Vol 25, Num 5, pp 755-758, issn 0301-5629Article

Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseasesSTANGEL, M; TOYKA, K. V; GOLD, R et al.Archives of neurology (Chicago). 1999, Vol 56, Num 6, pp 661-663, issn 0003-9942Article

Multifocal brain MRI hypointensities secondary to embolic metal fragments from a mechanical heart valve prosthesis : A possible source of epileptic seizuresNAUMANN, M; HOFMANN, E; TOYKA, K. V et al.Neurology. 1998, Vol 51, Num 6, pp 1766-1767, issn 0028-3878Article

Meningeal hyperfusion visualized by MRI in a patient with visual hallucinations and migraineLINDNER, A; REINERS, K; TOYKA, K. V et al.Headache. 1996, Vol 36, Num 1, pp 53-57, issn 0017-8748Article

Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis ratsJUNG, S; TOYKA, K. V; HARTUNG, H.-P et al.Neuroscience letters. 1995, Vol 200, Num 3, pp 167-170, issn 0304-3940Article

Primary rat astroglial cultures can generate leukotriene B₄HARTUNG, H.-P; HEININGER, K; TOYKA, K. V et al.Journal of neuroimmunology. 1988, Vol 19, Num 3, pp 237-243, issn 0165-5728Article

Analysis of immunoglobulin and T cell receptor gene rearrangements in the thymus of myasthenia gravis patientsTESCH, H; HOHLFELD, R; TOYKA, K. V et al.Journal of neuroimmunology. 1989, Vol 21, Num 2-3, pp 169-176, issn 0165-5728, 8 p.Article

Leukotriene production by cultured astroglial cellsHARTUNG, H.-P; TOYKA, K. V.Brain research. 1987, Vol 435, Num 1-2, pp 367-370, issn 0006-8993Article

Outcome in juvenile-onset myasthenia gravis : a retrospective study with long-term follow-up of 79 patientsLINDNER, A; SCHALKE, B; TOYKA, K. V et al.Journal of neurology. 1997, Vol 244, Num 8, pp 515-520, issn 0340-5354Article

Cyclophosphamid in der Therapie der chronisch-progredienten Multiplen Sklerose. Kritische Analyse der vorliegenden Studien = Treatment of chronic progressive multiple sclerosis by cyclophosphamide: critical analysis of the published trialsPETTE, M; HARTUNG; TOYKA, K. V et al.Nervenarzt. 1994, Vol 65, Num 4, pp 271-274, issn 0028-2804Article

Substance P: binding properties and studies on cellular responses in guinea pig macrophagesHARTUNG, H.-P; WOLTERS, K; TOYKA, K. V et al.The Journal of immunology (1950). 1986, Vol 136, Num 10, pp 3856-3863, issn 0022-1767Article

Adult-onset mixed myopathy with nemaline rods, minicores, and central cores: a muscle disorder mimicking polymyositisSEITZ, R; TOYKA, K. V; WECHSLER, W et al.Journal of neurology. 1984, Vol 231, Num 3, pp 103-108, issn 0340-5354Article

Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosisKAHL, K. G; KRUSE, N; TOYKA, K. V et al.Journal of the neurological sciences. 2002, Vol 200, Num 1-2, pp 53-55, issn 0022-510XArticle

Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosisCURSIEFEN, S; FLACHENECKER, P; TOYKA, K. V et al.European neurology. 2000, Vol 43, Num 3, pp 186-187, issn 0014-3022Article

Familial mixed congenital myopathy with rigid spine phenotypeREICHMANN, H; GOEBEL, H. H; SCHNEIDER, C et al.Muscle & nerve. 1997, Vol 20, Num 4, pp 411-417, issn 0148-639XArticle

Escalating immunotherapy of multiple sclerosisRIECKMANN, P; TOYKA, K. V.European neurology. 1999, Vol 42, Num 3, pp 121-127, issn 0014-3022Article